Your browser doesn't support javascript.
loading
Feasibility Assessment of Using the Complete Patient-Reported Outcomes Version of the Common Terminology Criteria for Adverse Events (PRO-CTCAE) Item Library.
Shepshelovich, Daniel; McDonald, Kate; Spreafico, Anna; Razak, Albiruni R A; Bedard, Philippe L; Siu, Lillian L; Minasian, Lori; Hansen, Aaron R.
Afiliação
  • Shepshelovich D; Princess Margaret Cancer Centre, Drug Development Program, University Health Network, Toronto, Canada.
  • McDonald K; Sackler School of Medicine, Tel Aviv University, Tel Aviv, Israel.
  • Spreafico A; Department of Medicine, University of Toronto, Toronto, Canada.
  • Razak ARA; Princess Margaret Cancer Centre, Drug Development Program, University Health Network, Toronto, Canada.
  • Bedard PL; Princess Margaret Cancer Centre, Drug Development Program, University Health Network, Toronto, Canada.
  • Siu LL; Department of Medicine, University of Toronto, Toronto, Canada.
  • Minasian L; Princess Margaret Cancer Centre, Drug Development Program, University Health Network, Toronto, Canada.
  • Hansen AR; Department of Medicine, University of Toronto, Toronto, Canada.
Oncologist ; 24(4): e146-e148, 2019 04.
Article em En | MEDLINE | ID: mdl-30728278
ABSTRACT
The patient-reported outcomes version of the Common Terminology Criteria for Adverse Events (PRO-CTCAE) complements capture of symptomatic adverse events (AEs) by clinicians. Previous trials have typically used a limited subset of relevant symptomatic AEs to reduce patient burden. We aimed to determine the feasibility of administering all 80 AEs included in the PRO-CTCAE library by approaching consecutive patients enrolled in a large academic phase I program at three points in time. Here, we report a preplanned analysis after enrolling the first 20 patients. All items were answered on 51 of 56 potential visits (adherence 91%). Three (5%) additional PRO-CTCAE assessments were partially completed, and two (4%) were missed because of conflicting appointments. No patient withdrew consent or chose not to complete the assessments once enrolled on study. Future trials of experimental drugs that incorporate the PRO-CTCAE should consider using this unselected approach to identify adverse events more completely.
Assuntos

Texto completo: 1 Eixos temáticos: Pesquisa_clinica Base de dados: MEDLINE Assunto principal: Sistemas de Notificação de Reações Adversas a Medicamentos / Efeitos Colaterais e Reações Adversas Relacionados a Medicamentos / Medidas de Resultados Relatados pelo Paciente / Neoplasias / Antineoplásicos Tipo de estudo: Etiology_studies / Observational_studies / Prognostic_studies / Risk_factors_studies Limite: Adult / Aged / Female / Humans / Male / Middle aged País como assunto: America do norte Idioma: En Ano de publicação: 2019 Tipo de documento: Article

Texto completo: 1 Eixos temáticos: Pesquisa_clinica Base de dados: MEDLINE Assunto principal: Sistemas de Notificação de Reações Adversas a Medicamentos / Efeitos Colaterais e Reações Adversas Relacionados a Medicamentos / Medidas de Resultados Relatados pelo Paciente / Neoplasias / Antineoplásicos Tipo de estudo: Etiology_studies / Observational_studies / Prognostic_studies / Risk_factors_studies Limite: Adult / Aged / Female / Humans / Male / Middle aged País como assunto: America do norte Idioma: En Ano de publicação: 2019 Tipo de documento: Article